Stay updated with breaking news from Halberd Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With markets reaching new all-time highs, numerous opportunities arise in penny stocks, considering both technical and fundamental analysis. We've pinpointed five companies based on their recent...
/PRNewswire/ -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...
Halberd (OTCMKTS:HALB – Get Rating) is one of 343 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to similar companies based on the strength of its valuation, earnings, profitability, risk, analyst recommendations, institutional ownership and dividends. Insider & Institutional Ownership 22.3% of shares […]
Halberd (OTCMKTS:HALB – Get Rating) is one of 361 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Halberd to related companies based on the strength of its analyst recommendations, profitability, earnings, dividends, institutional ownership, valuation and risk. Institutional and Insider Ownership 26.0% of shares of all […]
Halberd Co. (OTCMKTS:HALB – Get Rating) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 88,700 shares, an increase of 14.0% from the March 31st total of 77,800 shares. Based on an average daily volume of 3,158,700 shares, the days-to-cover […]